Correction

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (vol 26, pg 149, 2012)

Journal

LEUKEMIA
Volume 26, Issue 5, Pages 1153-1153

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2012.15

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available